Sponsored by:

Video from SNMMI: Cathy Cutler on the state of the field in 2025

Will Morton, Associate Editor, AuntMinnie.com. Headshot
Will Morton
Jun 24, 2025

NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, SNMMI President Cathy Cutler, PhD, discussed developments over the last year, as well as challenges facing the field moving ahead, such as securing stable supplies of radioisotopes. Cutler is chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, NY.

Latest in Molecular Imaging
Manufacturing Facility Process 400
Niowave expands supply agreement with AstraZeneca
December 18, 2025
Expand your field of view with new Biograph Trinion.X PET/CT
Sponsored
Expand your field of view with new Biograph Trinion.X PET/CT
November 13, 2025
Pet Ct Scanner
Nuclear medicine groups launch effort to standardize PET imaging
December 17, 2025
Isotopes1
RadioMedix secures Th-228 supply
December 17, 2025
Related Stories
Wang Ioy Image Thumbnail
Molecular Imaging
SNMMI: New immuno-PET tracer awarded Image of the Year
Coronal fused FDG-PET/MRI image of a patient with right upper back pain demonstrates asymetric uptake in the right trapezius muscle without abnormality on MRI to suggest edema or denervation injury. Trigger point lidocaine injection of the area based on PET/MRI findings resulted in complete relief of symptoms (pain score reduced to 0 from a baseline of 6).
Molecular Imaging
SNMMI: PET/MRI helps manage patients with chronic spinal pain
Cathy Cutler Ph D Snmmi President 2024 Thumbnail
2024
Cutler named president of SNMMI
Expand your field of view with new Biograph Trinion.X PET/CT
Sponsor Content
Expand your field of view with new Biograph Trinion.X PET/CT
More in Molecular Imaging
Niowave expands supply agreement with AstraZeneca
By AuntMinnie.com staff writers
Niowave is expanding its supply agreement with AstraZeneca to a 10-year commitment to deliver actinium-225.
December 18, 2025
Manufacturing Facility Process 400
AtomVie signs supply agreement with Ionetix for Ac-225 development
By AuntMinnie.com staff writers
AtomVie has entered a strategic partnership with Ionetix for the development of actinium-225 (Ac-225) for AtomVie's partners worldwide.
December 18, 2025
Business Handshake 400
Nuclear medicine groups launch effort to standardize PET imaging
By AuntMinnie.com staff writers
PET system accreditation methods vary widely across clinical research organizations, sponsors, and professional networks.
December 17, 2025
Pet Ct Scanner
RadioMedix secures Th-228 supply
By AuntMinnie.com staff writers
The supply will support the company's advancing cancer therapeutics pipeline.
December 17, 2025
Isotopes1
Early PET/CT feasible in women with suspected breast cancer
By Will Morton
Early imaging is not only more patient-friendly but also has the potential to simplify clinical workflows.
December 12, 2025
2025 12 12 Fapi Breast Cancer Thumbnail
Phase I trial reveals the potential of a new PSMA-PET tracer
By Will Morton
The radiotracer detected more lesions in men with metastatic disease than F-18 piflufolastat.
December 9, 2025
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
TVR-PET/CT shows promise in primary hyperparathyroidism
By Will Morton
Gallium-68 trivehexin PET/CT was superior for identifying lesions over technetium-99m sestamibi SPECT.
December 8, 2025
Phpt
PiB-PET/CT detects subtypes in cardiac amyloidosis
By Will Morton
PiB-PET/CT shows strong promise as a next-generation diagnostic tool for cardiac amyloidosis.
December 5, 2025
Heart
SNMMI notes pros and cons in CMS final 2026 OPPS rule
By AuntMinnie.com staff writers
The final rule includes two new Healthcare Common Procedure Coding System (HCPCS) codes relevant to nuclear medicine.
November 26, 2025
Snmmi
New SPECT/CT tracer visualizes distribution of ALS drug
By Will Morton
Tofersen has been approved for treating amyotrophic lateral sclerosis (ALS), but its regional brain uptake is not fully understood.
November 25, 2025
SPECT imaging of Tc-99m MAG3-tofersen in healthy human volunteers. (A) Maximum-intensity-projection images showing distribution of Tc-99m MAG3-tofersen in humans (n = 3) one, four, and 24 hours after intrathecal injection. Time–activity curves derived from SPECT data measuring activity in ROIs in CNS (lumbar, thoracic, and cervical spine ROIs include both cord and proximal CSF) (B), kidneys and liver (C), and brain atlas (D).
ConcertAI launches new reimbursement tool
By AuntMinnie.com staff writers
AI-powered platform tailored to payer requirements for reimbursable imaging biomarkers.
November 21, 2025
Money Bills Sky Line
UCLA to launch department of nuclear medicine and theranostics
By AuntMinnie.com staff writers
The University of California, Los Angeles (UCLA) will open a department of nuclear medicine and theranostics on January 1, 2026.
November 19, 2025
Nuclearmedicine
Page 1 of 618
Next Page